Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis

ASV Shah, D Stelzle, KK Lee, EJ Beck, S Alam… - Circulation, 2018 - Am Heart Assoc
Background: With advances in antiretroviral therapy, most deaths in people with HIV are
now attributable to noncommunicable illnesses, especially cardiovascular disease. We …

HIV infection and stroke: current perspectives and future directions

LA Benjamin, A Bryer, HCA Emsley, S Khoo… - The Lancet …, 2012 - thelancet.com
HIV infection can result in stroke via several mechanisms, including opportunistic infection,
vasculopathy, cardioembolism, and coagulopathy. However, the occurrence of stroke and …

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society–USA panel

MA Thompson, JA Aberg, JF Hoy, A Telenti, C Benson… - Jama, 2012 - jamanetwork.com
Context New trial data and drug regimens that have become available in the last 2 years
warrant an update to guidelines for antiretroviral therapy (ART) in human immunodeficiency …

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious …

GM Lucas, MJ Ross, PG Stock… - Clinical Infectious …, 2014 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Screening for HIV: US preventive services task force recommendation statement

VA Moyer - Annals of internal medicine, 2013 - acpjournals.org
Chinese translation Description: Update of the 2005 US Preventive Services Task Force
(USPSTF) recommendation statement on screening for HIV. Methods: The USPSTF …

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel

HF Günthard, JA Aberg, JJ Eron, JF Hoy, A Telenti… - Jama, 2014 - jamanetwork.com
Importance New data and antiretroviral regimens expand treatment choices in resource-rich
settings and warrant an update of recommendations to treat adults infected with human …

HIV and coronary heart disease: time for a better understanding

F Boccara, S Lang, C Meuleman, S Ederhy… - Journal of the American …, 2013 - jacc.org
Cardiovascular disease, and particularly coronary heart disease, is an emerging area of
concern in the HIV population. Since the advent of efficient antiretroviral therapies and the …

Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review

C Bavinger, E Bendavid, K Niehaus, RA Olshen… - PloS one, 2013 - journals.plos.org
Background Recent studies suggest certain antiretroviral therapy (ART) drugs are
associated with increases in cardiovascular disease. Purpose We performed a systematic …

Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Abacavir Dosing

MA Martin, TE Klein, BJ Dong… - Clinical …, 2012 - Wiley Online Library
Human leukocyte antigen B (HLA‐B) is responsible for presenting peptides to immune cells
and plays a critical role in normal immune recognition of pathogens. A variant allele, HLA‐B …

Neurological and psychiatric adverse effects of antiretroviral drugs

MS Abers, WX Shandera, JS Kass - CNS drugs, 2014 - Springer
Antiretroviral drugs are associated with a variety of adverse effects on the central and
peripheral nervous systems. The frequency and severity of neuropsychiatric adverse events …